[Summary] Consolidated Financial Results for the Six Months Period of Fiscal 2026 (Six Month Period Ended September 30, 2026) [JGAAP]11/9 15:30TDnetPDF(225KB)
Notice Regarding Absorption-Type Merger (Simplified Merger/Short-Form Merger) of a Consolidated Subsidiary11/9 15:30TDnetPDF(141KB)
Supplementary Financial Information Consolidated Financial Results for the Six Months Period Ended September 30, 202611/9 15:30TDnetPDF(328KB)
[Summary] Consolidated Financial Results for the Three-Months Period of Fiscal 2026 (Three-Month Period Ended June 30, 2026) [JGAAP]8/7 15:30TDnetPDF(248KB)
「KP-483」非臨床試験及び第I相試験結果の発表について ―American Society of Clinical Oncology (ASCO) 2026にて発表―6/1 11:00TDnetPDF(233KB)
[Summary] Consolidated Financial Results for the Fiscal Year Ended March 31, 2026 [JGAAP]5/13 15:30TDnetPDF(154KB)
Updates on Actions to Implement Management that is Conscious of Cost of Capital and Stock Price5/13 15:30TDnetPDF(765KB)
Notice Regarding Differences Between Non-Consolidated Financial Results and Results for the Previous Fiscal Year5/13 15:30TDnetPDF(183KB)